Challenges in constructing genetic instruments for pharmacologic therapies

B. A. Ference, G. Davey Smith, M. V. Holmes +3

The genes that encode the targets of most therapies do not have rare variants with large-effect or common variants with moderate effects on the biomarker reflecting the pharmacolog…